Literature DB >> 25388208

Integrin activation.

Mark H Ginsberg1.   

Abstract

Integrin-mediated cell adhesion is important for development, immune responses, hemostasis and wound healing. Integrins also function as signal transducing receptors that can control intracellular pathways that regulate cell survival, proliferation, and cell fate. Conversely, cells can modulate the affinity of integrins for their ligands a process operationally defined as integrin activation. Analysis of activation of integrins has now provided a detailed molecular understanding of this unique form of "inside-out" signal transduction and revealed new paradigms of how transmembrane domains (TMD) can transmit long range allosteric changes in transmembrane proteins. Here, we will review how talin and mediates integrin activation and how the integrin TMD can transmit these inside out signals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25388208      PMCID: PMC4345508          DOI: 10.5483/bmbrep.2014.47.12.241

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


INTRODUCTION

Integrins, heterodimeric type I transmembrane proteins consisting of α and β subunits, are a major class of receptors involved in adhesive events that control development and lead to pathologies such as cancer and thrombosis. Eighteeen integrin α subunits and 8 β subunits heterodimerize to form 24 different integrins (1). Each subunit contains a single transmembrane domain (TMD) and a short cytoplasmic tail. Besides mediating cell adhesion, integrins transmit signals across the plasma membrane that regulate cell migration, cell survival and growth (2). Conversely, signals from inside cells can increase the binding of integrin extracellular domains to ligands, a process operationally defined as integrin activation. Integrin activation encompasses both changes in affinity of individual integrins due to conformational changes and avidity increases due to integrin clustering (3-5). Precise regulation of integrin activation is particularly important in controlling platelet aggregation through integrin αIIbβ3 (6). Rapid activation of this integrin at the site of a wound is required for hemostasis (7); conversely inappropriate activation of αIIbβ3 can cause a platelet thrombus to occlude a blood vessel resulting in myocardial infarction or stroke. Here we will discuss recent progress in understanding how integrins are activated.

INTEGRIN TMD-THE CONDUIT FOR ALLOSTERIC REARRANGEMENTS

Changes in the conformation of integrin extracellular domains are responsible for the changes in integrin monomer affinity. These conformational changes have been the subject of several excellent reviews (3, 8-12) and will not be discussed here. Similarly, clustering of integrins can enchance the binding of multivalent ligands and kindlins have recently emerged as major players in clustering (13). The capacity of intracellular signals to change the conformation of the extracellular domain requires a remarkable transmemebrane allosteric change, a change that must traverse the integrin TMD. Truncation of the integrins at the C-termini of extracellular domains results in constitutively active integrins (14), indicating that TMDs and cytoplasmic tails limit the activation state of integrins. Furthermore, many activating mutations, map to the α or β TMD (15-18). Heterodimeric interactions between α and β TMDs and cytoplasmic tails have been observed by co-immunoprecipitation (19), cysteine crosslinking (20, 21) and by NMR (22) in phospholipid bicelles, but not in detergent micelles (23). Importantly, mutations in TMDs that activate integrins invariably inhibit α and β TMD interactions (19). Thus, physiological integrin activation is likely to require that intracellular signals disrupt integrin αβ TMD interactions. The structure of the αIIbβ3 TMD complex in a phospholipid bicelle (22) revealed the basis of association of the α and β through two interaction interfaces. The αIIb TMD helix is short, straight and broken at Gly991, the first residue of the highly-conserved Gly-Phe-Phe-Lys-Arg (GFFKR) motif in the membrane proximal region of the α subunits. The two Phe residues of the αIIb GFFKR motif do not form a continuous helix but instead make a sharp turn toward β3 (Fig. 1). In this way, the hydrophobic side chains of those residues reside in the hydrophobic core of the lipid bilayer and stack against hydrophobic residues in the β3 TMD, particularly Trp715 and Ile719. The turning of the membrane-proximal region of αIIb also permits the long-predicted (24) electrostatic interaction between αIIb Arg995 and β3 Asp723 by placing those residues in proximity (Fig. 1). The structure at the inner membrane interface is unique to and likely conserved in integrins and is termed the inner membrane clasp (IMC) (22). The second interface involves helical packing centered on β3 Gly708 and αIIb G972XXXG976 motif at the outer membrane region and is termed the outer membrane clasp (OMC) (Fig. 1). Integrin β3 TMD makes a long and continuous helix with a 25° tilting angle to enable the multipoint interactions with αIIb and accommodate the extra hydrophobic residues in the β3 TMD.
Fig. 1.

Structure of integrin αIIbβ3 TMD (ribbon view; αIIb in red and β3 in blue. From PDB 2K9J) showing the two interaction interfaces. Right, outer membrane clasp (OMC) illustrating the helical packing involving αIIb Gly 702 and 706. Left, inner membrane clasp (IMC) showing the electrostatic interaction between αIIb Arg995 and β3 Asp723. Also depicted are the hydrophobic interactions of αIIb Phe992,933 with the β3 TMD. Adapted from reference (22).

As noted above, an important feature of the structure of the αIIbβ3 TMD dimer is that the helical β TMD must be precisely tilted to maintain simultaneous formation of the OMC and IMC. Precise tilt is maintained via β3 Lys716 whose alpha carbon resides in the hydrophobic region of the lipid bilayer but its positively charged ε-NH3+ is predicted to snorkel into the negatively charged phosphate head group region (25). Mutation of Lys716 any residue other than Arg (which also contains a snorkeling basic side chain) reduces α-β TMD interactions and dramatically increases integrin activation (25). The effects of Lys716 mutation can be ameliorated by breaking the continuous β TMD helix into two halves by introduction of a Pro mutation (A711P). The Pro mutation, introduces a flexible hinge that partially decouples the tilting angles of inner and outer helices favoring simultaneous formation of OMC and IMC (25).

TALIN “TILTS” THE INTEGRIN β TMD TO INDUCE ACTIVATION

Talin regulates integrin affinity and provides a mechanical link between integrins and the actin cytoskeleton. Talin comprises a 50-kDa N-terminal FERM domain (talin head domain or THD) that contains a high-affinity binding site for integrin β tails and a 220-kDa rod domain that contains multiple binding sites for actin and vinculin (26). The THD is further divided into F0, F1, F2 and F3 subdomains (26, 27). The F3 subdomain, contains the major integrin integrin β tail binding site (28, 29). The essential role of talin in regulating integrin affinity has been well documented in model cells (29-32), transgenic mice (33-36) and reconstituted systems with purified proteins (37). In in vitro systems, recombinant THD alone is sufficient to activate αIIbβ3 reconstituted in either liposomes or phospholipid nanodiscs, and activation is associated with a shift towards an αIIbβ3 extended conformation (37). We now have considerable insight into how talin induces this allosteric rearrangement in integrins. Talin binds to two sites on integrin β tails: a strong binding site centered around the first NPxY motif that contributes most of the binding free energy and a weaker membrane proximal (MP) binding site (38). In addition, THD also binds to negatively charged phospholipids via positively-charged residues (38-40). The weak interaction with the MP region has two important effects: 1) it brings talin Lys324 close to Asp723 of the β3 tail, thus competing for the Arg995-Asp723 electrostatic interactions in IMC (40); 2) it stabilizes α-helical structure of the β MP region and to form a continuous helix with the β3 TMD (38, 40). As the simultaneous interaction with integrin β tails and phospholipids, can change the tilt angle of the β3 MP tail and thus of the contiguous β3 TMD (Fig. 2) (41). Such talin-induced motion was demonstrated by increased fluorescence of solvatochromic dyes attached to the N- or C-terminii of the β3 TMD in the presence of THD (41) and is further supported by molecular dynamic simulations (42). The change in tilting angle destabilizes α-β TMD interactions and shifts the equilibrium towards an activated integrin conformation. In further support of this model, introducing a flexible proline kink in the middle of the β3 TMD blocks THD-induced tilting of the outer membrane segment without blocking tilting of the inner membrane segment (Fig. 3). Integrins bearing this mutation are remarkably resistant to talin induced integrin activation (41).
Fig. 2.

Talin changes the topology of the β3 TMD. A peptide containing the β3 TMD and cytoplasmic domain was labeled with environment sensitive bimanes at the outer edge of the TMD (N terminal labeling, Leu694) or at the TMD cytosol interface (C-terminal labeling, Ile721). The peptides were individually embedded in phospholipid nanodiscs and increasing concentrations of talin head domain (THD) were added and bimanes emission spectra were recorded. The increased fluorescence indicates that both sides of the β3 TMD were in a less polar environment suggesting that THD increased the tilting of the β3 TMD. Adapted from reference (41).

Fig. 3.

A proline kink prevents transmission of altered tilt across the β3 TMD. In the left two panels The experimental design was identical to that in Fig. 2 and depicts the talin-induced increased embedding at both the inner (where THD binds) and outer edges of the TMD. Introduction of a flexible kink by β3 (A711P) mutation (right two panels) prevents the transmission of increased embedding of the inner TMD to the outer region. Adapted from reference (41).

SUMMARY AND CONCLUSIONS

Integrin activation was first observed in 1978 in integrin αIIbβ3 and it has proved to be a conserved property of β1, β2, and β3 integrins. As summarized here, our understanding of this unique form of transmembrane signal transduction has moved from a black box in which agonists, such as thrombin, caused a change in the affinity of integrin αIIbβ3. Today, cell biological and reverse genetic experiments have verified that talin binding to the integrin β cytoplasmic domain is a final common step in activation. Structural studies have revealed how two binding interfaces of talin with the integrin in combination with talin membrane binding sites can effect this form of transmembrane allostery. Studies have also revealed unique features of the heterodimeric integrin TMD that form a stable yet dynamic αβ TMD interaction that enables transmission of the activation signal across the phospholipid bilayer. The lessons learned in studying integrin transmembrane signaling, such as the importance of snorkeling basic residues in maintaining TMD topology, are likely to pertain to other examples of transmembrane signaling through transmembrane receptors.
  42 in total

Review 1.  Conformational regulation of integrin structure and function.

Authors:  Motomu Shimaoka; Junichi Takagi; Timothy A Springer
Journal:  Annu Rev Biophys Biomol Struct       Date:  2001-10-25

2.  The phosphotyrosine binding-like domain of talin activates integrins.

Authors:  David A Calderwood; Boxu Yan; Jose M de Pereda; Begoña García Alvarez; Yosuke Fujioka; Robert C Liddington; Mark H Ginsberg
Journal:  J Biol Chem       Date:  2002-04-03       Impact factor: 5.157

3.  Oligomerization of the integrin alphaIIbbeta3: roles of the transmembrane and cytoplasmic domains.

Authors:  R Li; C R Babu; J D Lear; A J Wand; J S Bennett; W F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

4.  Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.

Authors:  David A Calderwood; Yosuke Fujioka; Jose M de Pereda; Begoña García-Alvarez; Tetsuya Nakamoto; Ben Margolis; C Jane McGlade; Robert C Liddington; Mark H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

5.  Activation of integrin alphaIIbbeta3 by modulation of transmembrane helix associations.

Authors:  Renhao Li; Neal Mitra; Holly Gratkowski; Gaston Vilaire; Rustem Litvinov; Chandrasekaran Nagasami; John W Weisel; James D Lear; William F DeGrado; Joel S Bennett
Journal:  Science       Date:  2003-05-02       Impact factor: 47.728

Review 6.  Integrins: bidirectional, allosteric signaling machines.

Authors:  Richard O Hynes
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

7.  Breaking the integrin hinge. A defined structural constraint regulates integrin signaling.

Authors:  P E Hughes; F Diaz-Gonzalez; L Leong; C Wu; J A McDonald; S J Shattil; M H Ginsberg
Journal:  J Biol Chem       Date:  1996-03-22       Impact factor: 5.157

8.  Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets.

Authors:  C L Wagner; M A Mascelli; D S Neblock; H F Weisman; B S Coller; R E Jordan
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

Review 9.  Integrins: dynamic scaffolds for adhesion and signaling in platelets.

Authors:  Sanford J Shattil; Peter J Newman
Journal:  Blood       Date:  2004-06-17       Impact factor: 22.113

10.  A specific interface between integrin transmembrane helices and affinity for ligand.

Authors:  Bing-Hao Luo; Timothy A Springer; Junichi Takagi
Journal:  PLoS Biol       Date:  2004-06-15       Impact factor: 8.029

View more
  52 in total

1.  The Role of Integrin Expressing Cells in Modulating Disease Susceptibility and Progression (January 2016).

Authors:  Aftab A Ansari; Siddappa N Byrareddy
Journal:  Int Trends Immun       Date:  2016-01

Review 2.  Talin and Kindlin as Integrin-Activating Proteins: Focus on the Heart.

Authors:  Chao Chen; Ana Maria Manso; Robert S Ross
Journal:  Pediatr Cardiol       Date:  2019-07-31       Impact factor: 1.655

3.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance.

Authors:  Giray Enkavi; Matti Javanainen; Waldemar Kulig; Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Rev       Date:  2019-03-12       Impact factor: 60.622

Review 4.  Astrocytes in Migration.

Authors:  Jiang Shan Zhan; Kai Gao; Rui Chao Chai; Xi Hua Jia; Dao Peng Luo; Guo Ge; Yu Wu Jiang; Yin-Wan Wendy Fung; Lina Li; Albert Cheung Hoi Yu
Journal:  Neurochem Res       Date:  2016-11-11       Impact factor: 3.996

5.  Roles of integrin β3 cytoplasmic tail in bidirectional signal transduction in a trans-dominant inhibition model.

Authors:  Jiansong Huang; Yulan Zhou; Xiaoyu Su; Yuanjing Lyu; Lanlan Tao; Xiaofeng Shi; Ping Liu; Zhangbiao Long; Zheng Ruan; Bing Xiao; Wenda Xi; Quansheng Zhou; Jianhua Mao; Xiaodong Xi
Journal:  Front Med       Date:  2016-09-07       Impact factor: 4.592

Review 6.  Focal adhesion kinase signaling in unexpected places.

Authors:  Elizabeth G Kleinschmidt; David D Schlaepfer
Journal:  Curr Opin Cell Biol       Date:  2017-02-16       Impact factor: 8.382

7.  Talin regulates integrin β1-dependent and -independent cell functions in ureteric bud development.

Authors:  Sijo Mathew; Riya J Palamuttam; Glenda Mernaugh; Harini Ramalingam; Zhenwei Lu; Ming-Zhi Zhang; Shuta Ishibe; David R Critchley; Reinhard Fässler; Ambra Pozzi; Charles R Sanders; Thomas J Carroll; Roy Zent
Journal:  Development       Date:  2017-10-09       Impact factor: 6.868

8.  Regulation of inside-out β1-integrin activation by CDCP1.

Authors:  Sara G Pollan; Fangjin Huang; Jamie M Sperger; Joshua M Lang; Colm Morrissey; Anne E Cress; C Y Chu; Neil A Bhowmick; Sungyong You; Michael R Freeman; Danislav S Spassov; Mark M Moasser; William G Carter; Shakti Ranjan Satapathy; Kavita Shah; Beatrice S Knudsen
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

Review 9.  Periostin and TGF-β-induced protein: Two peas in a pod?

Authors:  Deane F Mosher; Mats W Johansson; Mary E Gillis; Douglas S Annis
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-08-10       Impact factor: 8.250

10.  Phosphatidylinositol 3-Kinase/Akt Mediates Integrin Signaling To Control RNA Polymerase I Transcriptional Activity.

Authors:  Chuanyue Wu; Jin You; Jijun Fu; Xingshun Wang; Yandong Zhang
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.